Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (2): 346-352. doi: 10.19723/j.issn.1671-167X.2020.02.024

Previous Articles     Next Articles

Effect of concentrated growth factors combined with guided tissue regeneration in treatment of classⅡ furcation involvements of mandibular molars

Fei LI,Jing QIAO,Jin-yu DUAN,Yong ZHANG,Xiu-jing WANG()   

  1. First Clinical Division, Peking University School and Hospital of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100034, China
  • Received:2018-08-08 Online:2020-04-18 Published:2020-04-18
  • Contact: Xiu-jing WANG E-mail:wang_xiu_jing@163.com
  • Supported by:
    Supported by the New Technology and New Treatment Foundation of Peking University School;Hospital of Stomatology, the National Natural Science Foundation of China(81600868);the Cao Caifang Periodontal Gengyun Foundation of Peking University School and Hospital of Stomatology(2016)

RICH HTML

 14   

PDF (PC)

265

Abstract:

Objective: Tissues loss due to periodontal disease is typically treated by a variety of rege-nerative treatment modalities, including bone grafts, guided tissue regeneration (GTR) and growth factors, to reform the supporting tissues of teeth. Concentrated growth factors (CGF) are produced by centrifuging blood samples at alternating and controlled speeds using a special centrifuge. The purpose of this study was to evaluate whether GTR could improve the effect of CGF combined with bone graft in the treatment of classⅡ furcations of mandibular molars.Methods: In the present study, thirty-five classⅡ furcation involvements were included and randomly divided into two groups. The experimental group (n=17) accepted GTR combined with CGF and bone graft therapy, and the controlled group (n=18) accepted CGF combined with bone graft therapy. The clinical examinations and cone beam computed tomography (CBCT) were performed at baseline and 1 year post-surgery. Comparisons of clinical and CBCT data before and after operation between the experimental group and the control group were made.Results: The clinical and CBCT data of both groups were not statistically different at baseline (P>0.05). At the end of 1 year post-surgery, the clinical parameters of both groups were significantly improved (P<0.001). The probing depths of the experimental group were (4.81±1.95) mm and (3.56±1.94) mm, respectively, significantly higher than the changes of the control group (P<0.001). The vertical and horizontal attachment gains of the experimental group were (4.11±1.98) mm and (3.84±1.68) mm, respectively, significantly higher than the changes of the control group (P<0.001). At the end of 1 year post-surgery, the experimental group showed significantly higher bone gain at vertical and horizontal directions compared with those of the control group: (3.84±1.68) and (3.88±2.12) mm, respectively (P<0.001).Conclusion: Within the limitation of the present study, GTR showed positive role in the effect of CGF combined with bone graft in the treatment of classⅡ furcation involvements of mandibular molars.

Key words: Concentrated growth factors, Furcation involvement, Bone grafting, Guided tissue regeneration

CLC Number: 

  • R781.3

Table 1

The distribution of furcation involvement in experimental and controlled group"

Group Number of teeth Furcation location Total
Buccal Lingual
Experimental group 11 9 8 17
Controlled group 11 9 9 18

Figure 1

Schematic diagram of marking points of CBCT for furcation involvements CEJ, cementoenamel junction; FE, furcation entrance; BP, bottom of bone pocket; DH, deepest site of horizontal bone loss; BL-H, bone loss in the horizontal direction, the distance from furcation entrance to the deepest site of horizontal bone loss; BL-V, bone loss in the vertical direction, the distance from furcation entrance to the bottom of bone pocket."

Figure 2

Preparation of concentrated growth factors A, three blood fractions were obtained through centrifuge process, a superior phase represented by the serum, an interim phase represented by a very large and dense polymerized fibrin block containing the CGF, white blood cells and stem cells, and the lower red blood cell layer; B, CGF."

Figure 3

Preparation of CGF-Bio-Gide-CGF sandwich membraneA, CGF membrane; B, Bio-Gide membrane; C, CGF-Bio-Gide-CGF sandwich membrane."

Figure 4

The baseline, in surgery and post-surgery of patient no.5 in the experimental group A, baseline; B, intrasurgical findings; C, bone graft mixed with CGF; D, mixture in site; E, CGF-Bio-Gide-CGF sandwich membrane in site; F, wound closed;G,1 year post-surgery."

Figure 5

CBCT images of patient no.5 of the experimental group at baseline"

Figure 6

CBCT images of patient no.5 of the experimental group at 1 year post-surgery"

Figure 7

The baseline, in surgery and post-surgery of patient no.4 in the control group A, baseline; B, intrasurgical findings; C, mixture in site; D, CGF membrane in site; E, wound closed; F, 1 year post-surgery."

Figure 8

CBCT images of patient no.4 of the control group at baseline"

Figure 9

CBCT images of patient no.4 of the control group at 1 year post-surgery"

Table 2

Clinical measurements of experimental and controlled group at baseline and 1 year post-surgery"

Items Experimental group Controlled group
PPD/mm, $\bar{x}±s$
Baseline 7.86±2.47 7.73±2.15
1 year post-surgery 3.05±1.33* 4.17±2.09*
PPD reduction 4.81±1.95# 3.56±1.94
REC/mm, $\bar{x}±s$
Baseline 1.42±0.87 1.48±0.69
1 year post-surgery 2.12±1.05* 2.14±1.03*
REC increase 0.70±0.63 0.66±0.62
CAL-V/mm, $\bar{x}±s$
Baseline 9.28±2.65 9.21±2.51
1 year post-surgery 5.17±1.48* 6.31±2.45*
Vertical attachment gain 4.11±1.98# 2.90±2.01
CAL-H/mm, $\bar{x}±s$
Baseline 6.08±2.31 6.05±2.44
1 year post-surgery 2.24±1.29* 3.35±1.67*
Horizontal attachment gain 3.84±1.68# 2.70±1.47

Table 3

The CBCT data of experimental and controlled group at baseline and 1 year post-surgery"

Items Experimental group Controlled group
BL-V/mm, $\bar{x}±s$
Baseline 6.01±2.34 6.04±2.58
1 year post-surgery 2.17±1.49* 3.15±1.37*
Vertical radiograph bone gain 3.84±1.68# 2.89±2.03
BL-H/mm, $\bar{x}±s$
Baseline 6.75±2.44 6.73±2.57
1 year post-surgery 2.87±2.02* 4.21±2.07*
Horizontal radiograph bone gain 3.88±2.12# 2.52±2.26
[1] Janssen KM , Vissink A, de Smit MJ, et al.Lessons to be learned from periodontitis[J]. Curr Opin Rheumatol, 2013,25(2):241-247.
[2] Trombelli L, Farina R . Clinical outcomes with bioactive agents alone or in combination with grafting or guided tissue regeneration[J]. J Clin Periodontol, 2008,35(8 Suppl):117-135.
[3] Stoecklin-Wasmer C ,Rutjes AW,da Costa BR,et al.Absorbable collagen membranes for periodontal regeneration: a systematic review[J]. J Dent Res, 2013,92(9):773-781.
[4] Susin C, Fiorini T, Lee J , et al. Wound healing following surgical and regenerative periodontal therapy[J]. Periodontol 2000, 2015,68(1):83-98.
[5] Martin P . Wound healing--aiming for perfect skin regeneration[J]. Science, 1997,276(5309):75-81.
[6] Giannobile WV, Finkelman RD, Lynch SE . Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I[J]. J Periodontol, 1994,65(12):1158-1168.
[7] Qiao J, An N, Ouyang X . Quantification of growth factors in different platelet concentrates[J]. Platelets, 2017,28(8):774-778.
[8] Rodella LF, Favero G, Boninsegna R , et al. Growth factors, CD34 positive cells, and fibrin network analysis in concentrated growth factors fraction[J]. Microsc Res Tech, 2011,74(8):772-777.
[9] 乔静, 段晋瑜, 褚祎 , 等. 浓缩生长因子在下颌磨牙Ⅱ度根分叉病变再生治疗中的应用[J]. 北京大学学报(医学版), 2017,49(1):36-42.
[10] Hamp SE, Nyman S, Lindhe J . Periodontal treatment of multiroo-ted teeth. Results after 5 years[J]. J Clin Periodontol, 1975,2(3):126-135.
[11] Qiao J, Duan J, Zhang Y , et al. The effect of concentrated growth factors in the treatment of periodontal intrabony defects [J].Future Sci OA, 2016, 2(4): FS136.
[12] Pirpir C, Yilmaz O, Candirli C , et al. Evaluation of effectiveness of concentrated growth factor on osseointegration[J]. Int J Implant Dent, 2017,3(1):7.
[13] Shyu SS, Fu E, Shen EC . Clinical and microcomputed topography evaluation of the concentrated growth factors as a sole material in a cystic bony defect in alveolar bone followed by dental implantation: a case report[J]. Implant Dent, 2016,25(5):707-714.
[14] Masuki H, Okudera T, Watanebe T , et al. Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF)[J]. Int J Implant Dent, 2016,2(1):19.
[15] Sahin IO, Gokmenoglu C, Kara C . Effect of concentrated growth factor on osteoblast cell response[J]. J Stomatol Oral Maxillofac Surg, 2018,119(6):477-481.
[16] Qin J, Wang L, Sun Y , et al. Concentrated growth factor increases Schwann cell proliferation and neurotrophic factor secretion and promotes functional nerve recovery in vivo[J]. Int J Mol Med, 2016,37(2):493-500.
[17] Pontoriero R, Lindhe J, Nyman S , et al. Guided tissue regeneration in degree Ⅱ furcation-involved mandibular molars. A clinical study[J]. J Clin Periodontol, 1988,15(4):247-254.
[18] Needleman I, Tucker R, Giedrys-Leeper E , et al. A systematic review of guided tissue regeneration for periodontai infrabony defects[J]. J Periodont Res, 2002,37(5):380-388.
[19] Behring J, Junker R, Walboomers XF , et al. Toward guided tissue and bone regeneration: morphology, attachment, proliferation, and migration of cells cultured on collagen barrier membranes. A systematic review[J]. Odontology, 2008,96(1):1-11.
[20] Felipe M, Andrade PF, Grisi MFM , et al. Comparison of two surgical procedures for use of the acellular dermal matrix graft in the treatment of gingival recession: a randomized controlled clinical study[J]. J Periodontol, 2007,78(7):1209-1217.
[21] Pajnigara NG, Kolte AP, Kolte RA , et al. Volumetric assessment of regenerative efficacy of demineralized freeze-dried bone allograft with or without amnion membrane in grade Ⅱ furcation defects: a cone beam computed tomography study[J]. Int J Periodontics Restorative Dent, 2017,37(2):255-262.
[22] Irokawa D, Takeuchi T, Noda K , et al. Clinical outcome of periodontal regenerative therapy using collagen membrane and deproteinized bovine bone mineral: a 2.5-year follow-up study[J]. BMC Res Notes, 2017,10(1):102.
[23] Kini V, Nayak DG, Uppoor AS . A clinical evaluation of biphasic calcium phosphate alloplast with and without a flowable bioabsorbable guided tissue regeneration barrier in the treatment of mandi-bular molar class Ⅱ furcation defects[J]. J Contemp Dent Pract, 2016,17(2):143-148.
[24] Bozkurt A, Apel C, Sellhaus B , et al. Differences in degradation behavior of two non-cross-linked collagen barrier membranes: an in vitro and in vivo study[J]. Clin Oral Implants Res, 2014,25(12):1403-1411.
[1] Bo-wen LI,Wei-yi WU,Lin TANG,Yi ZHANG,Yu-hua LIU. Barrier effect of improved porcine small intestinal submucosa absorbable membrane on early healing of mandibular defects in rabbits [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 887-892.
[2] ZHAN Ya-lin, HU Wen-jie, XU Tao, ZHEN Min, LU Rui-fang. Histomorphometric evaluation of ridge preservation after molar tooth extraction [J]. Journal of Peking University(Health Sciences), 2017, 49(1): 169-175.
[3] QIAO Jing, DUAN Jin-yu, CHU Yi, SUN Chang-zhou. Effect of concentrated growth factors on the treatment of degree Ⅱ furcation involvements of  mandibular molars [J]. Journal of Peking University(Health Sciences), 2017, 49(1): 36-042.
[4] CHEN Fei, PAN Shao-xia, FENG Hai-lan. Distribution and content of transforming growth factor-β1 and vascular endothelial growth factor in each layer of concentrated growth factors [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 860-865.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 456 -458 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 158 -161 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[6] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[7] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 109 -111 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 297 -301 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 505 -515 .
[10] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 599 -601 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd